US EditionNeurocrine Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Neurocrine CEO to highlight Dayspring’s role in treating chronic edema and update on clinical pipeline progress at the J.P. Morgan Healthcare Conference.
- At the 44th Annual J.P. Morgan Healthcare Conference, Neurocrine Biosciences will present at 8:15 A.M. PT, with a webcast on its Investors webpage.
- CEO Andy Doraiswamy, CEO of Neurocrine Biosciences will highlight the company’s growth and commercial momentum, spotlighting Dayspring non‑pneumatic compression treatment and pipeline clinical research.
- Company filings warn that Neurocrine Biosciences' press release contains forward‑looking statements and cautions readers not to place undue reliance, noting presentation dates and times are subject to change.
- The conference gives an opportunity to engage the global investment and healthcare community and demonstrate company strategy and execution to investors and stakeholders.
- Among other presenters, the conference, running January 12–15, 2026, in San Francisco, CA, features Xenon Pharmaceuticals Inc., emphasizing its broad industry participation.
68 Articles
68 Articles
The Billings Gazette
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
PALO ALTO, Calif., Jan. 7, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that senior management will present at the 44th Annual J.P. Morgan…
Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will present at the 44th…
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESS Newswire / January 7, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the J.P. Morgan 2026 Healthcare Conference on Wednesday, January…
Celltrion to present at the 44th Annual J.P. Morgan Healthcare Conference
INCHEON, South Korea, Jan. 6, 2026 /PRNewswire/ -- Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, today announced that Jin-Seok Seo, Chief Executive Officer and Hyuk-Jae Lee, Senior Executive Vice President at Celltrion, will present at the 44th Annual J.P.…
Montana Standard
Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference
TOKYO, Jan. 6, 2026 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced it will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, Calif. As…
Coverage Details
Bias Distribution
- 65% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium